NCT01177605已完成不适用
Assessment of Efficacy and Tolerance of a Follow-On Milk Containing a Mixture of Prebiotics Fed to Young Children in Salvador, Bahia, Brazil
Mead Johnson Nutrition2 个研究点 分布在 1 个国家开始时间: 2006年9月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 试验地点
- 2
研究概览
简要总结
This clinical study will evaluate the effect on incidence of diarrhea, respiratory illness, stool patterns and growth of two cow's milk-based beverages for children.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 9 Months 至 48 Months（Child）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Child 9 - 48 months of age
- •Child has consumed a cow follow-on milk during the 48 hours prior to enrollment
- •Child's weight for age is within the 10th -90th percentiles
- •Child's length for age is within 10th - 90th percentiles
- •Signed informed consent obtained
排除标准
- •Children who are receiving predominantly breast-milk
- •Serious concurrent illness
- •Children with diarrhea or acute respiratory infection during the 48 hours prior to randomization
- •Children with a history of underlying metabolic or chronic disease or congenital malformation which, in the opinion of the Investigator, is likely to interfere with the normal growth and development or the evaluation of the participant.
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Improved Respiratory Infection by Consuming Lactoferrin Fortified a2 Growing up Formula in Children of 2 to 3 Year OldRespiratory InfectionDiarrheal DiseaseNCT05670678a2 Milk Company Ltd.200
已完成
不适用
Efficacy and Tolerance of a Follow-On Formula Fed to Children From 12-48 Months of Age in Salvador, Bahia, BrazilDiarrheal DiseaseAcute Respiratory InfectionNCT01431469Mead Johnson Nutrition250
已完成
不适用
Efficacy and Tolerance of a Follow-On Formula Fed to Children From 36-48 Months of AgeDiarrheal DiseaseAcute Respiratory InfectionNCT01488435Mead Johnson Nutrition310
已完成
不适用
Iron Supplementation and Side EffectsIron OverloadIron Deficiency AnemiaNCT04018300Iowa State University17
已完成
1 期
Study Comparing the Gastro-intestinal Tolerability and Absorption Profile of Vortioxetine After Administration of Modified-release Formulations and Immediate-release Formulation in Healthy WomenHealthy WomenNCT02112903H. Lundbeck A/S40